Antitrust Antitrust

Forest Laboratories urges US judge to dismiss Bystolic pay-for-delay lawsuit

By Michael Acton
  • 14 Dec 2021 17:57
  • 14 Dec 2021 18:30
Lawyers for Forest Laboratories — now part of Allergan — urged a US judge in New York today to dismiss a lawsuit accusing the company of striking illegal pay-for-delay patent settlements with other drugmakers to delay the market entry of generic versions of beta blocker Bystolic.

During a lengthy hearing, Judge Lewis Liman

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News